Trials / No Longer Available
No Longer AvailableNCT00063791
A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Millennium Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to give patients who have had 4 or more prior lines of therapy for multiple myeloma access to VELCADE. The study is for patients who are not eligible for other clinical trials with VELCADE and for who VELCADE would otherwise not be available.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bortezomib |
Timeline
- First posted
- 2003-07-08
- Last updated
- 2007-02-14
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00063791. Inclusion in this directory is not an endorsement.